NASDAQ:SLGLSol Gel Technologies Stock Price, Forecast & News

Sol Gel Technologies' stock was trading at $8.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SLGL stock has decreased by 2.4% and is now trading at $8.05. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sol Gel Technologies.

Sol Gel Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Sol Gel Technologies.

Sol Gel Technologies Ltd (NASDAQ:SLGL) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.33) EPS for the quarter, topping the Zacks' consensus estimate of ($0.38) by $0.05. The company earned $3.47 million during the quarter, compared to analyst estimates of $3.37 million. Sol Gel Technologies had a negative net margin of 129.88% and a negative return on equity of 44.64%. View Sol Gel Technologies' earnings history.

4 brokerages have issued 1-year target prices for Sol Gel Technologies' shares. Their forecasts range from $21.00 to $33.00. On average, they expect Sol Gel Technologies' share price to reach $25.25 in the next year. This suggests a possible upside of 213.7% from the stock's current price. View analysts' price targets for Sol Gel Technologies.

Media coverage about SLGL stock has trended negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sol Gel Technologies earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Sol Gel Technologies.

Sol Gel Technologies saw a increase in short interest in June. As of June 30th, there was short interest totaling 69,300 shares, an increase of 12.0% from the June 15th total of 61,900 shares. Based on an average daily volume of 22,600 shares, the days-to-cover ratio is currently 3.1 days. Currently, 0.8% of the shares of the company are short sold. View Sol Gel Technologies' Current Options Chain.

Some companies that are related to Sol Gel Technologies include RAPT Therapeutics (RAPT), Radius Health (RDUS), Passage Bio (KROS), Eagle Pharmaceuticals (EGRX), Vanda Pharmaceuticals (VNDA), Ardelyx (ARDX), Stemline Therapeutics (STML), AnaptysBio (ANAB), Trillium Therapeutics (TRIL), Molecular Templates (MTEM), Atreca (BCEL), Kala Pharmaceuticals (KALA), Corbus Pharmaceuticals (CRBP), Collegium Pharmaceutical (COLL) and Athersys (ATHX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Teva Pharmaceutical Industries (TEVA), Tesla (TSLA), Advanced Micro Devices (AMD), eHealth (EHTH), Gilead Sciences (GILD), Iovance Biotherapeutics (IOVA), Micron Technology (MU) and NeoPhotonics (NPTN).

(SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SLGL stock can currently be purchased for approximately $8.05.

Sol Gel Technologies has a market capitalization of $164.14 million and generates $22.90 million in revenue each year. The company earns $-24,610,000.00 in net income (profit) each year or ($1.26) on an earnings per share basis.

The official website for Sol Gel Technologies is www.sol-gel.com.

Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The company can be reached via phone at 972-8931-3429 or via email at [email protected]